1. Phase I study of emedastine difumarate (KG-2413) (1). Single and consecutive administration studies using tablets of KG-2413;Nakajima;Kiso Rinsho,1989
2. Phase I study of emedastine difumarate (KG-2413) (2). Single and consecutive administration studies using capsules containing sustained release granules of KG-2413;Nakajima;Kiso Rinsho,1989
3. The biological fate of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl) benzimidazole difumarate (KB-2413) I. Absorption and excretion after oral administration to rats and guinea pigs;Sakai;Xenobio. Metab. Depos.,1987
4. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRC). I. Design of SCRS and its release controlling factor;Morita;J. Control. Release,2000
5. Influence of food on the bioavailability of drugs;Melander;Clin. Pharmacokinet.,1978